SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies to start 25 centres in next 36-48 months

13 Jun 2016 Evaluate

Thyrocare Technologies will increase the number of processing centres by 25 in next 36-48 months. This step will help to boost volume growth and expand its regional presence. It also aims to maintain the revenue growth of 30 percent in FY17.

The company’s topline grew by 32 percent to Rs 241 crore in fiscal year 2016. Its operating margin was around 40.2 percent and profit after tax saw a jump of 15 percent to Rs 51.80 crore in FY16.

Thyrocare Technologies is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.


 

Thyrocare Tech. Share Price

387.85 -4.75 (-1.21%)
21-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×